Cipla Gets Final Approval For Generic Version Of Revlimid :

NEW YORK CITY (dpa-AFX) - Cipla Limited has received final approval for its Abbreviated New Drug Application for Lenalidomide Capsule 5 mg, 10 mg, 15 mg and 25 mg from the FDA. Cipla's Lenalidomide

Related Keywords

Bristol Myers Squibb Revlimid , Cipla , More Such Health News , Abbreviated New Drug Application , Lenalidomide Capsule , Lenalidomide Capsules , Bristol Myers Squibb , Multiple Myeloma , Marginal Zone , Jets , Final , Approval , Generic , Version , Revlimid ,